These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

344 related articles for article (PubMed ID: 18634770)

  • 1. Randomized comparison of early inflammatory response after sirolimus-eluting stent vs bare metal stent implantation in native coronary lesions.
    Li JJ; Qin XW; Yang XC; Li ZC; Zeng HS; Xu B; Gao Z; Wu YJ; Zhang X; Zhang CY
    Clin Chim Acta; 2008 Oct; 396(1-2):38-42. PubMed ID: 18634770
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 5-year clinical outcomes after sirolimus-eluting stent implantation insights from a patient-level pooled analysis of 4 randomized trials comparing sirolimus-eluting stents with bare-metal stents.
    Caixeta A; Leon MB; Lansky AJ; Nikolsky E; Aoki J; Moses JW; Schofer J; Morice MC; Schampaert E; Kirtane AJ; Popma JJ; Parise H; Fahy M; Mehran R
    J Am Coll Cardiol; 2009 Sep; 54(10):894-902. PubMed ID: 19712798
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Firebird and cypher sirolimus-eluting stents and bare metal stents in treatment of very long coronary lesions.
    Fan L; Chen LL; Lin CG; Peng YF; Zheng XC; Luo YK; Zhang FL; Chen JH; Yan XP; Huang ZR
    Chin Med J (Engl); 2008 Aug; 121(16):1518-23. PubMed ID: 18982862
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcome of percutaneous hybrid coronary revascularization: bare metal stents jeopardize the benefit of sirolimus-eluting stents in the real world.
    Fineschi M; Gori T; Pierli C; Casini S; Sinicropi G; Buti A; Del Pasqua A; Bravi A
    Can J Cardiol; 2005 Dec; 21(14):1281-5. PubMed ID: 16341297
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the systemic levels of inflammatory markers after percutaneous coronary intervention with bare metal versus sirolimus-eluting stents.
    Rebeiz AG; Zoghbi E; Harb R; Youhanna S; Skouri HN; Dimassi A; Abou-Nader G; Nasrallah A; Sawaya J; Gharzuddine W; Alam S
    J Interv Cardiol; 2009 Apr; 22(2):169-74. PubMed ID: 19245380
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term clinical benefit of sirolimus-eluting stent implantation in diabetic patients with de novo coronary stenoses: long-term results of the DIABETES trial.
    Jiménez-Quevedo P; Sabaté M; Angiolillo DJ; Alfonso F; Hernández-Antolín R; SanMartín M; Gómez-Hospital JA; Bañuelos C; Escaned J; Moreno R; Fernández C; Fernández-Avilés F; Macaya C;
    Eur Heart J; 2007 Aug; 28(16):1946-52. PubMed ID: 17562666
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Three-year clinical outcome after primary stenting of totally occluded native coronary arteries: a randomized comparison of bare-metal stent implantation with sirolimus-eluting stent implantation for the treatment of total coronary occlusions (Primary Stenting of Totally Occluded Native Coronary Arteries [PRISON] II study).
    Rahel BM; Laarman GJ; Kelder JC; Ten Berg JM; Suttorp MJ
    Am Heart J; 2009 Jan; 157(1):149-55. PubMed ID: 19081412
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Randomized double-blind comparison of sirolimus-eluting stent versus bare-metal stent implantation in diseased saphenous vein grafts: six-month angiographic, intravascular ultrasound, and clinical follow-up of the RRISC Trial.
    Vermeersch P; Agostoni P; Verheye S; Van den Heuvel P; Convens C; Bruining N; Van den Branden F; Van Langenhove G
    J Am Coll Cardiol; 2006 Dec; 48(12):2423-31. PubMed ID: 17174178
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relation of C-reactive protein level and long-term risk of death or myocardial infarction following percutaneous coronary intervention with a sirolimus-eluting stent.
    Karha J; Bavry AA; Rajagopal V; Henderson MR; Ellis SG; Brener SJ
    Am J Cardiol; 2006 Sep; 98(5):616-8. PubMed ID: 16923447
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug-eluting stent for the treatment of small coronary lesion: comparison between sirolimus- and paclitaxel-eluting stent.
    Li JJ; Xu B; Yang YJ; Chen JL; Qiao SB; Ma WH; Qin XW; Yao M; Liu HB; Wu YJ; Yuan JQ; Chen J; You SJ; Dai J; Xia R; Gao RL
    Chin Med J (Engl); 2007 Apr; 120(7):569-73. PubMed ID: 17442204
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term outcome in patients treated with sirolimus-eluting stents in complex coronary artery lesions: 3-year results of the SCANDSTENT (Stenting Coronary Arteries in Non-Stress/Benestent Disease) trial.
    Kelbaek H; Kløvgaard L; Helqvist S; Lassen JF; Krusell LR; Engstrøm T; Bøtker HE; Jørgensen E; Saunamäki K; Aljabbari S; Thayssen P; Galløe A; Jensen GV; Thuesen L
    J Am Coll Cardiol; 2008 May; 51(21):2011-6. PubMed ID: 18498953
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term clinical follow-up after sirolimus-eluting stent versus bare metal stent implantation in patients with acute coronary syndrome.
    Ogita M; Nakamura T; Fujiwara N; Sakakura K; Funayama H; Sugawara Y; Kubo N; Ako J; Momomura S
    J Interv Cardiol; 2009 Jun; 22(3):216-21. PubMed ID: 19490360
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A single center investigation of bare-metal or drug-eluting stent restenosis from 1633 consecutive Chinese Han ethnic patients.
    Xu B; Li JJ; Yang YJ; Ma WH; Chen JL; Qiao SB; Qin XW; Yao M; Liu HB; Wu YJ; Yuan JQ; Chen J; You SJ; Dai J; Xia R; Gao RL
    Chin Med J (Engl); 2006 Apr; 119(7):533-8. PubMed ID: 16620692
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term clinical outcomes with sirolimus-eluting coronary stents: five-year results of the RAVEL trial.
    Morice MC; Serruys PW; Barragan P; Bode C; Van Es GA; Stoll HP; Snead D; Mauri L; Cutlip DE; Sousa E
    J Am Coll Cardiol; 2007 Oct; 50(14):1299-304. PubMed ID: 17903626
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use and long-term outcome of bare metal stent implantation in the drug-eluting stent era.
    Fujimoto H; Dohi T; Masuda J; Mitani H; Fujimoto Y; Maehara A; Nishiyama S; Nakanishi S; Yamaguchi T; Ishiwata S; Ohno M
    J Cardiol; 2007 Jun; 49(6):305-12. PubMed ID: 17633567
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of bare-metal and sirolimus- or paclitaxel-eluting stents for aorto-ostial coronary disease.
    Barlis P; Kaplan S; Dimopoulos K; Ferrante G; Di Mario C
    Cardiology; 2008; 111(4):270-6. PubMed ID: 18451644
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immediate and mid-term outcomes of sirolimus-eluting stent implantation for chronic total occlusions.
    Ge L; Iakovou I; Cosgrave J; Chieffo A; Montorfano M; Michev I; Airoldi F; Carlino M; Melzi G; Sangiorgi GM; Corvaja N; Colombo A
    Eur Heart J; 2005 Jun; 26(11):1056-62. PubMed ID: 15817605
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sirolimus versus bare metal stent implantation in patients with total coronary occlusions: subgroup analysis of the Stenting Coronary Arteries in Non-Stress/Benestent Disease (SCANDSTENT) trial.
    Kelbaek H; Helqvist S; Thuesen L; Kløvgaard L; Jørgensen E; Saunamäki K; Krusell LR; Bøtker HE; Engstrøm T; Jensen GV;
    Am Heart J; 2006 Nov; 152(5):882-6. PubMed ID: 17070149
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of changes in early inflammatory markers between sirolimus- and paclitaxel-eluting stent implantation.
    Li JJ; Yan HB; Xiang XP; Qin XW; Zhang CY
    Cardiovasc Drugs Ther; 2009 Apr; 23(2):137-43. PubMed ID: 19016317
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Limitation on efficacy of sirolimus-eluting stent implantation in patients on hemodialysis].
    Suzuki K; Inoue N; Matsuo A; Shiono Y; Nakanishi N; Otsuki Y; Nishibori Y; Inoue K; Tanaka T; Fujita H; Kitamura M; Nishimura M
    J Cardiol; 2007 Jun; 49(6):331-6. PubMed ID: 17633570
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.